Search for: "Anda Pharmaceuticals, Inc"
Results 21 - 40
of 605
Sorted by Relevance
|
Sort by Date
14 May 2015, 9:59 pm
Elan Pharmaceuticals,... [read post]
27 Dec 2022, 7:01 pm
These issues arose in ANDA litigation brought by Genentech and InterMune against ANDA filer Sandoz and its supplier LEK Pharmaceuticals. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
31 Jan 2017, 8:55 pm
§ 102(f), in Cumberland Pharmaceuticals Inc. v. [read post]
16 Apr 2012, 9:49 pm
Sunovion Pharmaceuticals Inc., the Federal Circuit affirmed a District Court's conclusion that it had subject-matter jurisdiction over a declaratory judgment action of a second ANDA filer, and as a result also affirmed the District Court's final judgment of non-infringement (based on a stipulation of the parties). [read post]
14 Oct 2015, 9:59 pm
Noonan -- Last week the Federal Circuit affirmed a District Court's finding of invalidity and non-infringement in ANDA litigation between Spectrum Pharmaceuticals and Sandoz. [read post]
22 Jan 2007, 6:39 pm
Cir. 2007, 06-1102) Caraco filed an ANDA with the intent to make and sell a pharmaceutical composition containing tramadol and acetaminophen with an average weight ratio of tramadol to acetaminophen of 1:8.67, and no less than a ratio of 1:7.5. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
4 Jan 2022, 8:39 pm
Accord Healthcare, Inc. [read post]
13 Aug 2020, 9:59 pm
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
30 Nov 2015, 7:12 am
" Jazz Pharmaceuticals, Inc. v. [read post]
12 Aug 2010, 9:57 pm
By Andrew Williams -- Last week, in King Pharmaceuticals, Inc. v. [read post]
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
17 May 2016, 8:30 pm
Glenmark Pharmaceuticals Inc., USA the Federal Circuit demonstrated the resulting equipoise in affirming a district court's determination that the doctrine applied to an accused infringing generic formulation. [read post]
8 Jan 2020, 8:57 pm
The case arose in ANDA... [read post]
12 Dec 2011, 9:59 pm
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
15 May 2012, 1:00 am
Sunovion Pharmaceuticals, Inc., the Federal Circuit affirmed the district court’s determination that it could exercise jurisdiction over a declaratory judgment action brought by a subsequent ANDA filer. [read post]
2 Sep 2016, 2:15 am
Mylan Pharmaceuticals, Inc., 817 F.3d 755 (Fed. [read post]
5 Jul 2018, 1:37 pm
Rockville-based biopharmaceutical company CASI Pharmaceuticals Inc. has been added to the Russell 2000, 3000 and Microcap Indexes, effective after U.S. market closed June 22. [read post]
2 Apr 2015, 9:59 pm
The first filer, Mylan Pharmaceuticals, Inc. [read post]